Early allopolyploid evolution in the post-Neolithic <i>Brassica napus</i> oilseed genome

Boulos Chalhoub, Shengyi Liu, Isobel A. P. Parkin, +77

Science

Plant GeneticsComparative GenomicsGeneticsGenomicsPlant Genomics +14

Mutational signatures reveal the dynamic interplay of risk factors and cellular processes during liver tumorigenesis

Éric Letouzé, Jayendra Shinde, Victor Renault, +14

Nature Communications

Variation in genomic landscape of clear cell renal cell carcinoma across Europe

Ghislaine Scélo, Yasser Riazalhosseini, Liliana Greger, +56

Nature Communications

UrologyGenitourinary CancerTumor HeterogeneityGenomic LandscapeMedicine +7

No association between complement factor H gene polymorphism and exudative age-related macular degeneration in Japanese

Norimoto Gotoh, Ryo Yamada, Hitomi Hiratani, +9

Human Genetics

Ocular DiseaseOphthalmologyGeneticsAge-related DiseasesGenetic Epidemiology +4

Cyclin A2/E1 activation defines a hepatocellular carcinoma subclass with a rearrangement signature of replication stress

Quentin Bayard, Léa Meunier, Camille Péneau, +19

Nature Communications

Deregulation of microRNA expression in purified T and B lymphocytes from patients with primary Sjögren's syndrome

Shufang Renault, Saida Boudaoud, Gaëtane Nocturne, +8

Annals of the Rheumatic Diseases

Novel landscape of HLA‐G isoforms expressed in clear cell renal cell carcinoma patients

Diana Tronik‐Le Roux, Julie Renard, Jérôme Verine, +7

Molecular Oncology

Integrated Genomic Analysis Identifies Driver Genes and Cisplatin-Resistant Progenitor Phenotype in Pediatric Liver Cancer

Théo Z. Hirsch, Jill Pilet, Guillaume Morcrette, +24

Cancer Discovery

Palimpsest: an R package for studying mutational and structural variant signatures along clonal evolution in cancer

Jayendra Shinde, Quentin Bayard, Sandrine Imbeaud, +5

Bioinformatics

STAT3 Mediates Nilotinib Response in KIT-Altered Melanoma: A Phase II Multicenter Trial of the French Skin Cancer Network

Julie Delyon, Sylvie Chevret, Thomas Jouary, +22

Journal of Investigative Dermatology

OncologyKit-altered MelanomaMedicineMelanomaImmune Checkpoint Inhibitor +5